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Low-level laser therapy (LLLT) has been targeted as a promising approach that can
mitigate post-infarction cardiac remodeling. There is some interesting evidence showing
that the beneficial role of the LLLT could persist long-term even after the end of the
application, but it remains to be systematically evaluated. Therefore, the present study
aimed to test the hypothesis that LLLT beneficial effects in the early post-infarction cardiac
remodeling could remain in overt heart failure even with the disruption of irradiations.
Female Wistar rats were subjected to the coronary occlusion to induce myocardial
infarction or Sham operation. A single LLLT application was carried out after 60 s and
3 days post-coronary occlusion, respectively. Echocardiography was performed 3 days
and at the end of the experiment (5 weeks) to evaluate cardiac function. After the
last echocardiographic examination, LV hemodynamic evaluation was performed at
baseline and on sudden afterload increases. Compared with the Sham group, infarcted
rats showed increased systolic and diastolic internal diameter as well as a depressed
shortening fraction of LV. The only benefit of the LLLT was a higher shortening fraction
after 3 days of infarction. However, treated-LLLT rats show a lower shortening fraction in
the 5th week of study when compared with Sham and non-irradiated rats. A worsening
of cardiac function was confirmed in the hemodynamic analysis as evidenced by the
higher LV end-diastolic pressure and lower +dP/dt and −dP/dt with five weeks of study.
Cardiac functional reserve was also impaired by infarction as evidenced by an attenuated
response of stroke work index and cardiac output to a sudden afterload stress, without
LLLT repercussions. No significant differences were found in the myocardial expression
of Akt1/VEGF pathway. Collectively, these findings illustrate that LLLT improves LV
systolic function in the early post-infarction cardiac remodeling. However, this beneficial
effect may be dependent on the maintenance of phototherapy. Long-term studies with
LLLT application are needed to establish whether these effects ultimately translate into
improved cardiac remodeling.
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INTRODUCTION
Myocardial infarction (MI) is a major cause for heart failure (HF)
development (Yancy et al., 2013). Data are showing that three
million people are affected by MI in the USA, and more than
400.000 new cases are reported for each year. In fact, ∼50% of
patients will die within 5 years, and 40% die 12 months after the
first HF hospitalization (Kolseth et al., 2014).
The acute MI triggers an adverse process known as cardiac
remodeling, in which there is left ventricular (LV) dilation and
enlargement of the ischemic tissue (Serra and Tucci, 2016).
Moreover, an impaired LV systolic and diastolic function and
a reduced myocardial inotropism are well-documented findings
(dos Santos et al., 2013; Antonio et al., 2015). Several mechanisms
are shown to be implicated in cardiac remodeling, including
adrenergic hyperactivity, renin-angiotensin-aldosterone system,
apoptosis, autophagy, fibrosis, inflammation, oxidative stress,
calcium handling abnormalities, and metabolic dysfunction
(Whelan et al., 2010; Carlos et al., 2016; Ziff et al., 2016).
Moreover, post-infarction cardiac remodeling is associated with a
higher prevalence of cardiac rupture, arrhythmias, and formation
of aneurysms. In the long term, there is the development of HF
and sudden death (Whelan et al., 2010; Ziff et al., 2016).
Several interventions have been proposed to alleviate cardiac
remodeling to prolong or prevent the development of HF (Carlos
et al., 2016). However, current therapies have shown only modest
results in survival or potential adverse properties (Yancy et al.,
2013; Grosman-Rimon et al., 2016). In latest years, experimental
studies have punctuated that the low-level laser therapy (LLLT)
may be a promising approach to modulate various biological
processes (Albertini et al., 2008; Pires et al., 2011). The LLLT
stimulates photoreceptors in themitochondrial respiratory chain,
resulting in increased ATP, increased growth factor secretion and
tissue healing (Tuby et al., 2006; Huang et al., 2011; Peplow
et al., 2012). A cardiac LLLT effect has been reported for over
10 years, in which infarcted rats showed a lower myocardial
necrosis (Oron et al., 2001b), LV dilatation (Ad and Oron, 2001;
Yaakobi et al., 2001), and most favorable milieu to prevent scar
disruptions (Whittaker and Patterson, 2000) with LLLT. More
recently, our group demonstrated reduced infarct size, attenuated
the systolic dysfunction and beneficial modulates inflammation
and expression of vasoactive peptides in rats submitted to LLLT
(Manchini et al., 2014).
In a recent systematic review, we have reported that many
studies have only assessed the LLLT role at MI early stage, in
which data reporting effects on the progression to HF are limited
(Carlos et al., 2016). Moreover, an intriguing is issue shown
to be an attenuated cardiac remodeling in animals submitted
to LLLT only at the initial phase of injury. In this regard, it
Abbreviations: MI, Myocardial infarction; HF, Heart failure; LLLT, Low-level
laser therapy; LV, Left ventricular; ATP, Adenosine triphosphate; NHI, National
Institutes of Health; MI-LLLT, Infarcted rats submitted with laser; MI-N, Infarcted
rats non-treated with laser; AlGaInP, Aluminum Indium Gallium Phosphorus;
EDP, End diastolic pressure;+dP/dt, Positive derivatives of the developed pressure;
-dP/dt, Negative derivatives of the developed pressure; SV, Stroke volume; SP,
Systolic pressure; SWI, Stroke work index; CO, Cardiac output; VEGF, Vascular
endothelial grow factor.
has been shown benefits of LLLT after several weeks post-MI,
e.g., decreased infarct size and cardiac dilation (Oron et al.,
2001b; Yaakobi et al., 2001). Although these data indicate that
the benefits of LLLT in the acute phase of MI may persist in
overt HF, there are some limitations that should be considered:
(i) there is no blinding for the experimental group or outcomes. A
more suitablemethodwould be to blind the infarct size and LLLT;
(ii) inclusion/exclusion criteria has not been stated (e.g., animals
with similar infarct sizes). The control of infarct size it seems
to be a key issue because the remodeling is intensified on larger
infarctions. Thus, it is doubtful to consider a beneficial cardiac
remodeling LLLT effect because of the intragroup infarct size
variability; (iii) there is only cross-sectional design studies, and
the causality results cannot be determined. Therefore, this study
was designed to determine whether LLLT application benefits at
the MI early stage remains in overt HF same with disruption of
treatment.
MATERIALS AND METHODS
Animals and Experimental Design
This study was carried out in accordance with the
recommendations of Guide for the Care and Use of Laboratory
Animals published by the US National Institutes of Health
(NHI, no. 85-23, revised 1996). The protocol was approved
by the Institutional Research Ethics Committee of the Nove
de Julho University, São Paulo, Brazil (number: 0015–2012).
Experiments were performed under ketamine (50 mg/kg), and
Xylazine (10mg/kg) mixture anesthesia, and efforts were made
to minimize the suffering of animals.
Figure 1 illustrates the experimental design. Forty-seven
female Wistar rats weighing 250–280 g were assigned to LLLT
or non-LLLT. The MI was produced by permanent arterial
coronary occlusion, and then rats were randomized to one of
the following groups: infarcted rats non-treated with LLLT (MI-
N, n = 7); infarcted rats submitted to LLLT (MI-LLLT, n = 6).
Sham rats (n = 8) were operated upon similarly, although the
coronary occlusion was avoided. The Sham and MI-N groups
were submitted to a similar LLLT procedure, yet the device was
kept off (placebo). Echocardiographic analyses were carried out
on 3 days and 5 weeks post-infarction. We have included in the
study only rats with large infarcts, which showed be defined on
the 3rd-day post-infarction as a size ≥ 37% of LV (dos Santos
et al., 2013). At the end of the 5-week, rats were euthanized by
decapitation according to a protocol detailed elsewhere (AVMA
Panel on Euthanasia. American Veterinary Medical Association,
2001). The infarct scar was removed from LV, and remote
myocardial tissue was immediately stored in a cryogenic tube and
kept frozen in liquid nitrogen for molecular analysis.
To date, nine rats died in coronary occlusion surgery, four
during the peri-operative period, and two in the hemodynamic
evaluation. We excluded 11 rats because they had infarct
sizes < 37%.
MI Model
The MI was induced according to a well-established technique
(Antonio et al., 2015). Briefly, under anesthesia and artificial
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FIGURE 1 | Experimental design protocol.
ventilation (Harvard Rodent Ventilator, Model 863; Harvard
Apparatus, Holliston, MA, USA), a left thoracotomy was
performed. The heart was exteriorized, and the left anterior
descending coronary artery was occluded near its origin with 6-
0 polypropylene. The heart was rapidly returned to its original
position and the thorax closed.
Phototherapy
Aluminum Indium Gallium Phosphorus—AlGaInP (Twin
Laser—MM Optics, São Carlos, SP, Brazil) was used for
irradiation under the parameters in Table 1. After thoracotomy,
the coronary occlusion was carried out as describe above, and
the heart was put in the chest to recover itself for 60 s and then
the organs was externalized. The laser/placebo was applied
directly to the myocardial tissue targeting infarcted area. In
the 3rd day, rats were anesthetized, and a new thoracotomy
was performed at the same surgical site to heart exteriorization
and laser/placebo application. Sham group was exposed to all
experimental procedures, though the LLLT device was off.
Echocardiography
Rats were anesthetized as described above (K-X mixture) and
LV echocardiography was performed using a 12-MHz transducer
connected to an HP Sonos-5500 (Hewlett–Packard, Palo Alto,
CA, USA). The infarct size was evaluated on transverse 2-
dimensional view and reported as percent of the LV perimeter on
the basal, mid transversal, and apical planes (Sofia et al., 2014).
The MI was defined as the presence of a segment with increased
echogenicity and modification in myocardial thickening or
systolic movement (hypokinesia, akinesia, or dyskinesia). Systolic
function was analyzed by the fractional shortening (Serra et al.,
2010). Diastolic function was not evaluated owing to the fusion
of the A and E waves.
LV Hemodynamic Study and Afterload
Stress
Immediately after echocardiography, baseline hemodynamic
evaluation was performed under adjusted anesthesia (K-X
mixture) and oxygen-enriched ventilation with a closed chest.
TABLE 1 | Protocol of LLLT irradiation.
Active laser medium AlGaInP
Power (mW) 15
Wave-length (nm) 660
Power density (W/cm2) 0.37
Density energy (J/cm2 ) 27.3
Spot size (cm2) 0.04
Time per point (sec) 73
Total energy per treatment (J) 1.1
Number of treatments (once a day) 2
Application mode Punctual in heart
The left femoral vein was accessed for drug administration,
and a 2-F gauge Millar catheter-tip micromanometer (model
SPR-320, Millar Instruments, Houston, TX, USA) was inserted
into the right carotid artery into the LV cavity. Moreover, an
ultrasound flow probe (Transonic System Inc., Ithaca, NY, USA)
was positioned in the ascending aorta. The following data were
analyzed (Acknowledge software, Biopac System, Santa Barbara,
CA, USA): LV systolic (SP) and end-diastolic pressures (EDP),
rate of change of LV pressure (+dP/dt and −dP/dt), heart rate,
and cardiac output (CO), and stroke volume (SV). Stroke work
index (SWI) was stated as previously described (dos Santos et al.,
2010). Thereafter, sudden LV afterload increases were achieved
using a single phenylephrine in bolus injection (15–25µg/kg, i.v.)
(dos Santos et al., 2010).
Biometric Data
After hemodynamic analysis, hearts were quickly removed and
weighed. Myocardial mass was indexed by body weight and used
as a hypertrophy marker.
Myocardial Fibrosis
Hearts were removed in 3 days and 5 weeks after infarction or
sham surgery and fixed in 4% buffered formaldehyde overnight.
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The LV fragments were washed with PBS, dehydrated through a
graded series of ethanol, diaphonized with Xylol and embedded
with paraplast. Samples were cut into 3 mm thick sections and
stained with Masson’s trichome. The fibrous tissue was evaluated
in 6 randomized 40 x magnification using a Nikon Eclipse E200
microscope and Nikon Infinity Optical System (Kurobane Nikon
Co., Tochigi, Japan), and Image Pro-Plus software, version 4.0
(Media Cybernetics Inc., Rockville, MD, USA).
Western Blot
Proteins were extracted from the LV remote area as previously
described by us (Silva et al., 2014). Homogenate protein samples
of 30 µg were subjected to SDS-PAGE in 10% polyacrylamide
gel. Separated proteins were transferred onto hydrophobic
polyvinylidene difluoride membranes (Hybond-P, Amersham
Biosciences; Piscataway, J, USA), and the transfer efficiency
was examined with 0.5% Ponceau S. The membranes were
soaked in a blocking buffer (5% nonfat dry milk and 0.1%
Tween 20 in PBS, pH 7.5) for 1 h at room temperature
and then incubated overnight at 4◦C with primary antibodies:
rabbit anti-Akt1 (1:5000 dilution; Abcam, Cambridge, MA,
USA); rabbit anti-phosphoSer473Akt1 (1:5000 dilution; Abcam,
Cambridge, USA); goat anti-VEGF (1:1000; Abcam, Cambridge,
MA, USA); anti-GAPDH (1:500; Santa Cruz Biotechnology,
Santa Cruz, CA, USA). After overnight incubation, membranes
were washed five times and then incubated for 1 h with
horseradish peroxidase-conjugated goat anti-rabbit and rabbit
anti-goat secondary antibodies (1:2000; Invitrogen, San Diego,
CA, USA). Membranes were finally washed five times with
blocking buffer and then rinsed twice in PBS. Bound antibody
was detected by using chemiluminescence reagent for 1min. The
bands were imaged by using Amersham Imager 600 system (GE
Health Care, Little Chalfont, UK). UK).
Statistical Analysis
Data were analyzed using GraphPad Prism software 5.0 (La
Jolla, CA, USA). Shapiro-Wilk test was used to verify normality
data. Levene test was applied to assess the equality of variances.
One-way ANOVA complemented by Newman–Keuls post hoc
was applied to detect differences between groups in cross-
section analysis. Two-way repeated ANOVA complemented by
Bonferroni post hoc was applied to paired data. Kruskal-Wallis
followed by Dunn’s multiple comparison tests were applied to
non-normality data. Statistical significance was set at p ≤ 0.05.
Data are expressed as mean± SD.
RESULTS
LLLT Does Not Affect Structural and
Functional Abnormalities of LV
The biometric data are shown in Table 2. Average body weight
was similar between the three experimental groups on the 3rd
day and 5 weeks of study. Infarcted rats showed a similar heart
mass as well as heart mass-to-body weight ratio when compared
with Sham rats, and phototherapy had no repercussion on heart
mass. Besides, phototherapy also had no effect on infarct size. As
evidenced in Figure 2, quantitative analysis for Masson trichome
staining indicated no significant differences in the collagen
content between experimental groups with 3 days post-MI.
However, infarcted rats showed a significant increase of fibrosis
over 5 weeks post-MI, in which LLLT had no significant effect.
As seen in Figure 3, there was LV dilatation with only 3
days post-infarction, in which diastolic diameter was significantly
higher in MI+LLLT group while the systolic diameter was higher
in all infarcted groups when compared with Sham group. At the
end of the 5-week experimental period, both diastolic and systolic
diameters were shown to be significantly increased in all infarcted
groups when compared with Sham group. The LV systolic
dysfunction was apparent early as the 3rd-day post-infarction, as
evidenced by a minor fractional shortening. The beneficial role
of LLLT was only noticed in the early (3 days) post-infarction
cardiac remodeling, in which the fractional shortening of the MI-
LLLT group was significantly higher than MI-N group. On the
other hand, treated-LLLT rats show a lower LV performance in
the 5th week of study when compared with Sham and MI-N rats.
Afterward second echocardiographic analysis, an invasive
hemodynamic evaluation was carried out to determine LV
ejection performance. As reported in Figure 4, data also indicate
deteriorating LV function, in which +dP/dt and −dP/dt values
were significantly lower in MI-N andMI-LLLT groups compared
with Sham group under basal conditions. In addition, a higher
EDP was reported only for MI-LLLT group, which also showed
a more marked reduction on −dP/dt when compared to MI-N
and Sham group. The LV ejection parameters from all infarcted
groups did not differ significantly from those of the Sham group
when evaluated under basal conditions, as evidenced by SWI
TABLE 2 | Biometric data.
3 days 5 weeks
Sham MI-N MI+LLLT Sham MI-N MI+LLLT
BW (g) 210 ± 29 192 ± 23 206 ± 30 239 ± 20 237 ± 17 245 ± 27
Heart mass (mg) – – – 1004 ± 138 894 ± 186 1062 ± 447
Heart mass/BW ratio – – – 4.3 ± 0.9 3.7 ± 0.7 4.2 ± 1.3
Infarct size (%) – 46 ± 16 44 ± 7 – 50 ± 7 49 ± 5
BW, body weight. Two-way repeated ANOVA was applied for body weight and infarct size analysis. ANOVA one way was applied for heart mass and heart mass index. There were no
significant differences as a result of time or phototherapy. Data are expressed as mean ± SD.
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FIGURE 2 | Representative microphotographs of remote myocardium with 3 days (A: Sham; B: MI-N; C: MI+LLLT) and 5 weeks (D: Sham; E: MI-N; F:
MI+LLLT) after MI. Myocardial sections were stained with Masson’s trichome. (G) Is representative of the statistical comparisons between experimental groups. Data
are means ± SD (n = 4 per group). P-values were determined by one-way ANOVA and post hoc Newman-Keuls test. Magnification 40x (scale bar: 50µm).
#p < 0.05 vs. 3 days.
FIGURE 3 | Effects of LLLT in the ventricular cavity and fractional shortening 3 days and 5 weeks after MI (Sham, n = 8; MI-N, n = 7; MI+LLLT, n = 6).
Compared with the Sham group, the left ventricular end diastolic diameter (LVDd) were significantly augmented in 3 days (MI+LLLT group) and 5 weeks (MI-N and
MI+LLLT). The left ventricular end systolic diameter (LVSd) was higher in all infarcted groups compared with Sham group (3 days and 5 weeks). The fractional
shortening of the MI-LLLT group was significantly higher than MI-N group on 3 day, however MI+LLLT showed significantly lower LV performance in 5 weeks when
compared with Sham and MI-N groups. Data are means ± SD. P-values were determined by two-way repeated ANOVA complemented by Bonferroni post-hoc.
#p < 0.05 vs. 3 days.
and CO. These findings led to analyze the cardiac functional
reserve during sudden afterload stress as a result of in bolus
phenylephrine injection. For suitable homogenization, we carried
out experiments to raise the blood pressure of 50–70% over the
baseline level (dos Santos et al., 2010). This afterload range was
accompanied by a higher increase of+dP/dt and−dP/dt in Sham
group than in all infarcted groups. Furthermore, CO decreased
more dramatically in all infarcted groups when compared with
Sham group. Ultimately, Sham rats showed SW increase, whereas
the SW was remarkably reduced in all infarcted rats.
Survival/Angiogenesis Factors Are Not
Affected by MI or LLLT
It has been postulated that the cardioprotective effects of
LLLT shown to be associated with increased angiogenesis, and
this action is linked to modulation of vascular endothelial
growth factor (VEGF) (Tuby et al., 2006, 2008). Thus, we have
investigated the Akt1/VEGF pathway in the remote myocardial
after 5 weeks following injury. Data in Figure 5 indicate that
the MI and phototherapy did not affect the expression of the
total Akt1, Akt1 phosphorylated at Serine 473 and Akt1/pAkt1
ratio, which is a marker of its activity. Notwithstanding, VEGF
expression was also not significantly different between the
experimental groups.
DISCUSSION
Data showing that LLLT application only at the MI early stage
could result in a long-term beneficial effect on cardiac remodeling
are intriguing. In fact, LLLT action has been achieved until several
weeks after discontinuing of the irradiation, e.g., a minor infarct
size (Oron et al., 2001b).
We showed here that the LLLT improved LV systolic
function only 3 days post-infarction, which confirms previous
data from our lab (Manchini et al., 2014). On the other
hand, we have not reported a cardioprotective LLLT role
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FIGURE 4 | Repercussion on baseline hemodynamic and sudden afterload after 5 weeks of MI (Sham, n = 8; MI-N, n = 7; MI+LLLT, n = 6). Data are
means ± SD. P-values were determined by one-way ANOVA and post hoc Newman-Keuls test. LVEDP: left ventricular end-diastolic pressure; +dP/dt: maximum
positive time derivative of developed pressure; −dP/dt: maximum negative derivative of developed pressure; SWI: stroke work index CO: cardiac output.
FIGURE 5 | The protein expression by western blot in the remote myocardium with 3 days and 5 weeks after MI. (A,E) Protein expression of Akt1. (B,F)
Protein expression of pAkt1. (C,G) Ratio of pAkt1/ Akt1. (D,H) Protein expression of VEGF. All values were normalized to levels of GAPDH (Sham, n = 8; MI-N, n = 7;
MI+LLLT, n = 6). Data are means ± SD. P-values were determined by one-way ANOVA and post hoc Newman-Keuls test.
during evolution to overt HF, as illustrated by the no effect
on infarct size, cavity dilation and LV systolic performance
at the end of the study. Yang et al. (2011) have published
similar findings in rats subjected to LLLT with up to 72
h post-infarction. Accordingly our data, these authors also
reported no beneficial LLLT effect in LV diastolic and systolic
diameter as well as LV performance on echocardiographic
analysis. We advance these findings to explore whether the
LLLT could increase functional heart reserve for an increased
LV afterload. In fact, a minor functional LV reserve shown
be a marker for cardiac remodeling progression (Fletcher
et al., 1981), in which it can be the result of a decreased
myocardial inotropism at a given loading level (Francis et al.,
2001). As illustrated in Figure 3, infarcted rats had exacerbated
LVEDP and decreased +dP/dt, −dP/dt, SW, and CO as a
response to sudden afterload increases. Mechanisms associated
with changes in cardiac performance are not fully clarified,
but they may be linked to an altered handling Ca2+ and
myofilament Ca2+ sensitivity (Pfeffer and Braunwald, 1990).
Moreover, post-infarct ventricular dilatation is shown to be
limiting for the intracavitary pressure development, as defined
by the Laplace (Pfeffer and Braunwald, 1990; dos Santos et al.,
2013). Importantly, LLLT had no effect on the functional cardiac
abnormalities.
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To our knowledge, infarct size has been the main variable
affected by LLLT, and many studies have shown a minor injury
size with several weeks post-LLLT application (Oron et al.,
2001a,b; Yaakobi et al., 2001; Yang et al., 2011). It is hard to
understand the differences of our findings to previously studies.
A key reason may be the randomization, in which we have
only included animals with large infarcts. The comparison of
experimental groups that have a similar infarct size at baseline
is a critical issue to avoid the causality of results and has not
been controlled in previous studies. Thus, while it may be
understood that the LLLT lead to a lower infarct size, it is possible
also that rats with lower infarct sizes have been included in
the LLLT-treated group. Moreover, previous investigations have
only carried out a cross-sectional analysis (Oron et al., 2001a;
Yaakobi et al., 2001; Yang et al., 2011), in which the causality
cannot be determined. In this regard, we have analyzed the
longitudinal repercussion of LLLT (Table 2) to clarify whether
infarct size at baseline (3 days) changed over time as an
effect of phototherapy. Other issues that show be investigated
to understand the differences in our findings for previously
studies are (i) the differences in irradiation parameters and (ii)
approach to analyzing the infarct size (e.g., histomorphometric
or echocardiographic).
Cardioprotective effects of LLLT are often attributed to
angiogenic factors in a wide range of tissues (Dourado et al.,
2011; Feng et al., 2012; Cury et al., 2013), including the
ischemicmyocardium (Tuby et al., 2006). Thus, there are findings
showing greater pro-angiogenic stimuli (e.g., VEGF expression)
in infarcted hearts that received LLLT only in the early MI
(Mirsky et al., 2002; Zhang et al., 2010). In our study, there was no
increased VEGF expression and its well-known downstream—
Akt with 3 days and 5 weeks post-MI. It is shown to be reported
that time of analysis of VEGF post-infarction may be a reason
for our findings. Zhao et al. (2010) conducted experiments on
infarcted rats to investigate the temporal expression of angiogenic
factors. The authors observed a significant increase in the VEGF
protein levels at the border zone only during day one post-MI
and with subsequent decline in 28 days. Consequently, we cannot
exclude an effect of LLLT on angiogenic VEGF signaling because
our analysis may have been influenced by the timeline.
In summary, our findings illustrate that LLLT improves LV
systolic function in the early post-infarction cardiac remodeling.
However, this beneficial effect may be dependent on the
maintenance of phototherapy. Long-term studies with LLLT
application are required to establish whether these effects
ultimately translate into improved cardiac remodeling.
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